IN PHOTOS: What goes into making a Covid-19 vaccine
Sequencing of the genome, setting the stage for manufacture, conducting clinical trials, signing agreements, as well as holding protests. Forbes India takes a look at the Covid-19 vaccination journey in countries across the globe
Curated By: Amit Verma
_20200904072811_930x584.jpg "Commonwealth Scientific and Industrial Research Organisation (CSIRO)")
_20200904074217_930x584.jpg "French National Centre for Scientific Research (CNIR)")
April
Robert Langer, co-founder of biotech firm Moderna at his Cape Cod residence in Massachusetts, US. Moderna was one of the first companies to react to the Covid-19 outbreak back in January. Along with the NIH (National Institute of Health), it began working on an mRNA vaccine candidate even before the first coronavirus cases outside of China had been confirmed. This potential Covid-19 vaccine has since entered Phase 3 of clinical trials, secured a funding boost of almost $500 million and been fast-tracked through regulatory protocols by the US Food and Drug Administration (FDA)
